Live Breaking News & Updates on Schizophrenia International Research Society

Stay updated with breaking news from Schizophrenia international research society. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Data from Newron's study 014/015 and an evenamide clinical development outlook presented at the 2024 Annual Congress of the Schizophrenia International Research Society (SIRS)

EQS-News: Newron Pharmaceuticals S.p.A. / Key word(s): Study results Data from Newron’s study 014/015 and an evenamide clinical development outlook presented at the 2024 Annual Congress of the Schizophrenia International Research Society (SIRS) 08.04.2024 / 07:00 CET/CEST The issuer is solely responsible for the content of this announcement. Data from Newron’s study 014/015 and an evenamide clinical development outlook presented at the 2024 Annual Congress of the Schizophrenia International ....

Newron-pharmaceuticals , Schizophrenia-international-research-society , Study-patients-evenamide-newron-treatment-data-from-health-press-release ,

Data from Newron's study 014/015 and an evenamide clinical development outlook presented at the 2024 Annual Congress of the Schizophrenia International Research Society (SIRS) -April 08, 2024 at 07:06 am EDT

Data from study 014/015, a phase II trial evaluating evenamide as add-on therapy for patients with treatment-resistant schizophrenia for up to one year

Presentation of study design for potentially. ....

United-kingdom , Seika , Kyongsang-bukto , South-korea , India , Sri-lanka , Switzerland , Japan , United-arab-emirates , Milan , Lombardia , Italy

Data from Newron's study 014/015 and an evenamide clinical development outlook presented at the 2024 Annual Congress of the Schizophrenia International Research Society (SIRS) | Region

MILAN (BUSINESS WIRE) Apr 8, 2024 ....

Canada , Milan , Lombardia , Italy , Switzerland , Seika , Kyongsang-bukto , South-korea , India , United-kingdom , Sri-lanka , United-states

Alkermes Presents Analyses From Long-Term Safety Study of LYBALVI® (olanzapine and samidorphan) at 2024 Congress of the Schizophrenia International Research Society

Alkermes Presents Analyses From Long-Term Safety Study of LYBALVI® (olanzapine and samidorphan) at 2024 Congress of the Schizophrenia International Research Society
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-states , Dublin , Ireland , Ohio , Italy , Waltham , Massachusetts , Athlone , Westmeath , Washington , American , Sandy-coombs

Bristol Myers reports positive Phase 3 data for schizophrenia drug (NYSE:BMY)

Bristol Myers reports positive Phase 3 data for schizophrenia drug (NYSE:BMY)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

Italy , Schizophrenia-international-research-society , Annual-congress ,